310 related articles for article (PubMed ID: 19443402)
1. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
[TBL] [Abstract][Full Text] [Related]
2. Nuclear morphometry in prognostication of breast cancer in Saudi Arabian patients: comparison with European and African breast cancer.
Buhmeida A; Al-Maghrabi J; Merdad A; Al-Thubaity F; Chaudhary A; Gari M; Abuzenadah A; Collan Y; Syrjänen K; Al-Qahtani M
Anticancer Res; 2010 Jun; 30(6):2185-91. PubMed ID: 20651368
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor, progesterone receptor, and nuclear size features in female breast cancer in Libya: correlation with clinical features and survival.
Abdalla FB; Markus R; Buhmeida A; Boder J; Syrjänen K; Collan Y
Anticancer Res; 2012 Aug; 32(8):3485-93. PubMed ID: 22843935
[TBL] [Abstract][Full Text] [Related]
4. 'Blind' multicenter evaluation of the prognostic value of DNA image cytometric and morphometric features in invasive breast cancer.
Theissig F; Baak JP; Schuurmans L; Haroske G; Meyer W; Kunze KD
Anal Cell Pathol; 1996 Mar; 10(2):85-99. PubMed ID: 8721952
[TBL] [Abstract][Full Text] [Related]
5. Proliferation in African breast cancer: biology and prognostication in nigerian breast cancer material.
Ikpatt OF; Kuopio T; Collan Y
Mod Pathol; 2002 Aug; 15(8):783-9. PubMed ID: 12181262
[TBL] [Abstract][Full Text] [Related]
6. The significance of nuclear morphometric variables as prognostic predictors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Kosma VM; Marin S; Alhava E; Syrjänen K
Anticancer Res; 1991; 11(4):1663-9. PubMed ID: 1746922
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of necrosis in Nigerian breast cancer.
Ikpatt O; Ndoma-Egba R; Collan Y
Adv Clin Path; 2002 Jan; 6(1):31-7. PubMed ID: 17582946
[TBL] [Abstract][Full Text] [Related]
8. Nuclear morphometry and mitotic indexes as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Eskelinen M; Alhava E; Syrjänen K
Eur J Surg; 1991 May; 157(5):319-24. PubMed ID: 1678644
[TBL] [Abstract][Full Text] [Related]
9. [Some morphometric parameters of nucleoli and nuclei in invasive ductal breast carcinomas in women].
Karpinska-Kaczmarczyk K
Ann Acad Med Stetin; 2009; 55(1):90-6. PubMed ID: 20349598
[TBL] [Abstract][Full Text] [Related]
10. Correlation of nuclear morphometry with pathologic parameters in ductal carcinoma in situ of the breast.
Tan PH; Goh BB; Chiang G; Bay BH
Mod Pathol; 2001 Oct; 14(10):937-41. PubMed ID: 11598161
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of nuclear morphometric risk grade as a prognostic factor of early breast cancer].
Watanabe T; Kimishima I; Abe R; Sano H; Furukawa Y; Nakayama K; Andou Y; Tsuchiya A
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():75-80. PubMed ID: 7747996
[TBL] [Abstract][Full Text] [Related]
12. Comparison of classic and quantitative prognostic factors in colorectal cancer.
Ropponen K; Eskelinen M; Kosma VM; Lipponen P; Paakkinen P; Alhava E
Anticancer Res; 1996; 16(6B):3875-82. PubMed ID: 9042274
[TBL] [Abstract][Full Text] [Related]
13. Quantitative prognostic features in FIGO I ovarian cancer patients without postoperative treatment.
Brugghe J; Baak JP; Wiltshaw E; Brinkhuis M; Meijer GA; Fisher C
Gynecol Oncol; 1998 Jan; 68(1):47-53. PubMed ID: 9454660
[TBL] [Abstract][Full Text] [Related]
14. Nuclear morphometry in human pancreatic adenocarcinoma; relation to histological grade, clinical stage, and survival.
Lipponen P; Eskelinen M; Collan Y
Ital J Gastroenterol; 1990 Jun; 22(3):124-8. PubMed ID: 1966706
[TBL] [Abstract][Full Text] [Related]
15. Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area.
Raabe NK; Schistad O; Sauer T; Bofin A; Kaaresen R; Fossaa SD
APMIS; 1997 May; 105(5):363-70. PubMed ID: 9201237
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of nuclear area index in patients with bladder cancer.
Yusup A; Kanamaru H; Aoki Y; Saikawa S; Moriyama N; Oyama N; Akino H; Okada K; Yokoyama O
Int J Urol; 2004 Jun; 11(6):374-8. PubMed ID: 15157205
[TBL] [Abstract][Full Text] [Related]
17. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
Ladekarl M
APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
[TBL] [Abstract][Full Text] [Related]
18. Nuclear volume and breast cancer prognosis.
Jalava P; Kronqvist P; Smrzova B; Juntti-Patinen L; Kuopio T; Collan YU
Anticancer Res; 2001; 21(1B):727-32. PubMed ID: 11299834
[TBL] [Abstract][Full Text] [Related]
19. Nuclear morphometry in breast cancer: the influence of sampling rules and freezing of samples.
Kronqvist P; Collan Y; Kuopio T; Kujari H
Mod Pathol; 1995 Feb; 8(2):187-92. PubMed ID: 7777482
[TBL] [Abstract][Full Text] [Related]
20. Nuclear morphometry as a predictor of disease outcome in gastric cancer.
Setälä L; Lipponen P; Kosma VM; Marin S; Eskelinen M; Syrjänen K; Alhava E
J Pathol; 1997 Jan; 181(1):46-50. PubMed ID: 9072002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
